FIFTH THIRD BANCORP

Bank

Position in GRFS — Grifols SA

CIK 35527 CINCINNATI, OH

Position in GRFS

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$807

-$1,967 QoQ

Shares Held

114

-67.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#151

of 164 holders

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FIFTH THIRD BANCORP holds $3,769,908,119 across 17 Drug Manufacturers - General names. GRFS ranks #17 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	1,750,788	$2,099,947,825
2	ABBV	AbbVie Inc.	2,151,394	$541,376,786
3	JNJ	Johnson & Johnson	1,943,962	$493,708,029
4	MRK	Merck & Co., Inc.	1,500,619	$192,829,541
5	AMGN	Amgen Inc	438,431	$158,764,633
6	PFE	Pfizer Inc	4,509,295	$108,583,823
7	GILD	Gilead Sciences, Inc.	719,424	$90,892,028
8	BMY	Bristol Myers Squibb Co	1,140,161	$65,696,076

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$807	114	-67.1%	Shares	Defined	2026-08-05
2026-03-31	$2,774	346	+203.5%	Shares	Defined	2026-05-01
2025-12-31	$1,065	114	0.0%	Shares	Defined	2026-02-02
2025-09-30	$1,135	114	0.0%	Shares	Defined	2025-11-07
2025-06-30	$1,030	114	-75.7%	Shares	Defined	2025-07-15
2021-09-30	$6,852	469	-57.2%	Shares	Defined	2021-10-15
2021-06-30	$18,998	1,095	+1.4%	Shares	Defined	2021-08-06
2021-03-31	$18,673	1,080	-91.8%	Shares	Defined	2021-05-07
2020-12-31	$243,500	13,205	-7.2%	Shares	Defined	2021-02-16
2020-09-30	$246,786	14,224	+5.6%	Shares	Defined	2020-11-09
2020-06-30	$245,638	13,467	+3.3%	Shares	Defined	2020-08-05
2020-03-31	$262,504	13,034	—	Shares	Defined	2020-05-05
No filing history on record for this holder in this stock.